Accera Obtains $10,000,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    380 Interlocken Crescent Broomfield, CO 80021
  • Company Description
    Accera is a private biotechnology company engaged in the discovery and development of innovative therapeutic treatments for neurodegenerative diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.